Congress Coverage
Clinical Collections
10-05-2023 | Case-Based Insights: Oncology and Hematology | Training Course
After obtaining all the necessary findings, you diagnose a 32-year-old female patient with Philadelphia-negative common ALL. Then you initiate induction therapy in conformity with the GMALL protocol. What do you have to consider, and what could the strategy for anti-infective prophylaxis look like here?